Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1479615 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $11.55Day −4.31%Mkt cap $1.6B1Y +95.1%Off 52W high −5.3%Vol (1Y) 80.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,360 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.1% of sh out |
| Days to cover3.1d |
| 13F net flow (QoQ)+1.93% |
| Top-10 13F concentration80.5% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$839,000 |
| Earnings (TTM)-$75.0M |
| ROE−90.3% |
| Net margin−15851.9% |
| Sales growth 3Y−70.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+90.0% |
| 1Y+95.1% |
| 3Y+110.0% |
| 5Y−55.6% |
| Since incept. (ann.)−15.0% |
Total return through 2026-07-28 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)80.4% |
| Ann. volatility (3Y)81.5% |
| Sharpe (1Y)1.24 |
| Sharpe (3Y)0.72 |
| Max drawdown (1Y)−41.9% |
| Max drawdown (3Y)−91.7% |
| Beta (3Y vs SPY)2.40 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 3.0M | $16M | 2.14% | +0.0% |
| Siren, L.L.C. | 2.9M | $15M | 2.05% | +0.0% |
| Redmile Group, LLC | 2.2M | $11M | 1.53% | +0.0% |
| Nantahala Capital Management, LLC | 2.1M | $11M | 1.51% | +39.2% |
| CITADEL ADVISORS LLC | 1.2M | $7M | 0.87% | +405.9% |
| MILLENNIUM MANAGEMENT LLC | 1.1M | $6M | 0.76% | +62.9% |
| GREAT POINT PARTNERS LLC | 1.0M | $5M | 0.72% | +26.3% |
| Nextech Invest, Ltd. | 952,400 | $5M | 0.67% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.11 | — | $422,000 | +197.2% |
| 2025-12-31 | 2026-03-05 | — | — | $34,000 | −99.9% |
| 2025-09-30 | 2025-11-06 | −$0.15 | — | $159,000 | −89.4% |
| 2025-06-30 | 2025-08-07 | −$0.19 | — | $224,000 | −70.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
GB 100%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
